SERUM LEVELS OF INTERFERON-GAMMA, CYTOTOXIC FACTOR AND SOLUBLE INTERLEUKIN-2 RECEPTOR IN CHILDHOOD HEMOPHAGOCYTIC SYNDROMES

被引：61

作者：

IMASHUKU, S

IKUSHIMA, S

ESUMI, N

TODO, S

SAITO, M

机构：

[1] Division of Pediatrics, Children's Research Hospital, and Department of Pediatrics, Kyoto Prefectural University of Medicine, Kyoto

[2] Applied Research Laboratory of Chugai Pharmaceutical Co. Ltd., Tokyo

来源：

LEUKEMIA & LYMPHOMA | 1991年 / 3卷 / 04期

关键词：

INTERFERON-GAMMA; CYTOTOXIC FACTOR; SOLUBLE INTERLEUKIN-2 RECEPTOR; MALIGNANT HISTIOCYTOSIS; VIRUS-ASSOCIATED HEMOPHAGOCYTIC SYNDROME;

D O I：

10.3109/10428199109107916

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Serum levels of interferon (IFN)-gamma, cytotoxic factor (CF) and soluble interleukin-2 receptor (sIL2R) were assayed in relation to hyperferritinemia in eleven cases of malignant histiocytosis (MH), seven of virus-associated hemophagocytic syndrome (VAHS) and one of familial erythrophagocytic lymphohistiocytosis (FEL). IFN-gamma was markedly elevated (>10,000 U/ml) in 5 MH cases and only in one case of VAHS. CF was significantly elevated (> 150 U/ml) in 5 MH and 4 VAHS/FEL patients. sIL2R were remarkably elevated (> 10,000 U/ml) in 5 MH and 4 VAHS patients. In individual cases, the patterns of these parameters were quite different, suggesting the existence of a variable pathophysiology in cases with hemophagocytic syndromes. In terms of the patients' outcome, high IFN-gamma or sIL2R levels were associated with a poor prognosis while high CF appeared to be associated with a better prognosis. © 1991 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted.

引用

页码：287 / 292

页数：6

共 32 条

[1] Byrne G.E., Rappaport H., Malignant histiocytosis, Malignant Diseases of the Hematopoietic System, pp. 145-162, (1973)
[2] Risdall R.J., McKenna R.W., Nesbit M.E., Et al., Virus-associated hemophagocytic syndrome: a benign histiocytic proliferation distinct from malignant histiocytosis, Cancer, 44, pp. 993-1002, (1979)
[3] Janka G.E., Familial hemophagocytic lymphohistiocytosis, Eur. J. Pediatr., 140, pp. 221-230, (1983)
[4] Komp D.M., McNamara J., Buckley P., Elevated soluble interleukin-2 receptor in childhood hemophagocytic hitiocytic syndromes, Blood, 73, pp. 2128-2132, (1989)
[5] Gray P.W., Goedel D.V., Structure of the human immune interferon gene, Nature, 298, pp. 859-863, (1982)
[6] Hooks J.J., Moutsopoulos H.M., Geis S.A., Et al., Immune interferon in the circulation of patients with autoimmune disease, N. Engl. J. Med, 301, pp. 5-8, (1979)
[7] Rhodes-Feuillette A., Canivet M., Chamsauer H., Et al., Circulating interferon in cytomegalovirus infected bonemarrow-transplant recipients and in infants with congenital cytomegalovirus disease, J. Interferon Res, 3, pp. 45-52, (1983)
[8] Ohno S., Kato F., Matsuda H., Et al., Detection of gamma interferon in the sera of patients with Behcet’s disease, Infection and Immunity, 36, pp. 202-208, (1982)
[9] Murray H.W., De Pamphilis J., Schooley R.T., Et al., Circulating interferon gamma in AIDS patients treated with interleukin-2, N. Engl. J. Med., 318, pp. 1538-1539, (1989)
[10] Girardin E., Grau E.G., Dayer J.-M., Et al., Tumor necrosis factor and interleukin-1 in the serum of children with severe infectious purpura, N. Engl. J. Med., 319, pp. 397-400, (1988)

← 1 2 3 4 →